Learn more about whether Biogen Inc. or Neurocrine Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and ...

K18 Biomimetic Hairscience, the cutting-edge biotech haircare brand, is proud to announce its upcoming launch at Cosmo Prof today. This marks the brand's continued expansion to support professional ...

Detailed price information for Tenaya Therapeutics Inc (TNYA-Q) from The Globe and Mail including charting and trades.

Increased cash balance and momentum with both Nasdaq and Phase 1 trial initiation mark strong beginning for 2025SOUTH SAN FRANSCISCO, Calif., ...

WOW.AI, an AI entertainment company, today announced it is launching the meme coin $WARS, to make a competitive bid for Infowars.com.  WOW.AI is aiming to acquire Infowars.com from the Alex Jones ...

SAN FRANCISCO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- TrialWire, a leader in clinical trial recruitment innovation, launched its groundbreaking AI Voice Screen service as part of the TrialWire Recruitment ...

After winning a breakthrough therapy designation for its Hunter syndrome enzyme replacement therapy, Denali Therapeutics is ...

Gladstone Institutes hopes to buy 103,400 square feet of life sciences research offices near its hub in San Francisco’s ...

Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...

LatchBio is building data and pipeline infrastructure to help biotechnology teams access and analyze data at scale.